|
|
Volumn 280, Issue 5367, 1998, Pages 1196-1197
|
|
Antibodies stage a comeback in cancer treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER ANTIBODY;
EDRECOLOMAB;
MONOCLONAL ANTIBODY;
PACLITAXEL;
RITUXIMAB;
TRASTUZUMAB;
TUMOR ANTIGEN;
UNCLASSIFIED DRUG;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CANCER RESEARCH;
CLINICAL TRIAL;
COLON CANCER;
DIARRHEA;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LYMPHOMA;
NAUSEA;
NOTE;
PRIORITY JOURNAL;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CLINICAL TRIALS;
COLONIC NEOPLASMS;
COMBINED MODALITY THERAPY;
HUMANS;
LYMPHOMA, B-CELL;
MICE;
NEOPLASMS;
|
|
EID: 0032557492
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.280.5367.1196 Document Type: Note |
|
Times cited : (57)
|
|
References (0)
|